These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 30711160)
21. Identification of plasma microRNA expression changes in multiple system atrophy and Parkinson's disease. Uwatoko H; Hama Y; Iwata IT; Shirai S; Matsushima M; Yabe I; Utsumi J; Sasaki H Mol Brain; 2019 May; 12(1):49. PubMed ID: 31088501 [TBL] [Abstract][Full Text] [Related]
22. Characterization of a novel panel of plasma microRNAs that discriminates between Mycobacterium tuberculosis infection and healthy individuals. Cui JY; Liang HW; Pan XL; Li D; Jiao N; Liu YH; Fu J; He XY; Sun GX; Zhang CL; Zhao CH; Li DH; Dai EY; Zen K; Zhang FM; Zhang CY; Chen X; Ling H PLoS One; 2017; 12(9):e0184113. PubMed ID: 28910318 [TBL] [Abstract][Full Text] [Related]
23. Identification of non-invasive biomarkers for chronic atrophic gastritis from serum exosomal microRNAs. Liu H; Li PW; Yang WQ; Mi H; Pan JL; Huang YC; Hou ZK; Hou QK; Luo Q; Liu FB BMC Cancer; 2019 Feb; 19(1):129. PubMed ID: 30736753 [TBL] [Abstract][Full Text] [Related]
24. Differential microRNA expression in the peripheral blood from human patients with COVID-19. Li C; Hu X; Li L; Li JH J Clin Lab Anal; 2020 Oct; 34(10):e23590. PubMed ID: 32960473 [TBL] [Abstract][Full Text] [Related]
25. Levels of microRNA miR-16 and miR-155 are altered in serum of patients with tuberculosis and associate with responses to therapy. Wagh V; Urhekar A; Modi D Tuberculosis (Edinb); 2017 Jan; 102():24-30. PubMed ID: 28061948 [TBL] [Abstract][Full Text] [Related]
26. Circulating hsa-miR-30e-5p, hsa-miR-92a-3p, and hsa-miR-223-3p may be novel biomarkers in systemic lupus erythematosus. Kim BS; Jung JY; Jeon JY; Kim HA; Suh CH HLA; 2016 Oct; 88(4):187-93. PubMed ID: 27596248 [TBL] [Abstract][Full Text] [Related]
27. Identifying quantitative sncRNAs signature using global sequencing as a potential biomarker for tuberculosis diagnosis and their role in regulating host response. Kaul S; Nair V; Gcanga L; Lakshmanan V; Kalamuddin M; Anang V; Rathore S; Dhawan S; Alam T; Khanna V; Lohiya S; Ali S; Mannan S; Rade K; Parihar SP; Khanna A; Malhotra P; Brombacher F; Dasaradhi PV; Guler R; Mohmmed A Int J Biol Macromol; 2024 Jun; 271(Pt 2):132714. PubMed ID: 38815937 [TBL] [Abstract][Full Text] [Related]
28. A 9-microRNA Signature in Serum Serves as a Noninvasive Biomarker in Early Diagnosis of Alzheimer's Disease. Guo R; Fan G; Zhang J; Wu C; Du Y; Ye H; Li Z; Wang L; Zhang Z; Zhang L; Zhao Y; Lu Z J Alzheimers Dis; 2017; 60(4):1365-1377. PubMed ID: 29036818 [TBL] [Abstract][Full Text] [Related]
29. Circulating microRNAs in patients with active pulmonary tuberculosis. Fu Y; Yi Z; Wu X; Li J; Xu F J Clin Microbiol; 2011 Dec; 49(12):4246-51. PubMed ID: 21998423 [TBL] [Abstract][Full Text] [Related]
30. Identification of MicroRNAs as Potential Blood-Based Biomarkers for Diagnosis and Therapeutic Monitoring of Active Tuberculosis. Kim J; Park H; Park SB; Lee EJ; Je MA; Ahn E; Sim B; Lee J; Jin H; Lee KE; Cho SN; Kang YA; Lee H; Kim S; Kim J Diagnostics (Basel); 2022 Feb; 12(2):. PubMed ID: 35204460 [TBL] [Abstract][Full Text] [Related]
31. MicroRNA profiling reveals dysregulated microRNAs and their target gene regulatory networks in cemento-ossifying fibroma. Pereira TDSF; Brito JAR; GuimarĂ£es ALS; Gomes CC; de Lacerda JCT; de Castro WH; Coimbra RS; Diniz MG; Gomez RS J Oral Pathol Med; 2018 Jan; 47(1):78-85. PubMed ID: 29032608 [TBL] [Abstract][Full Text] [Related]
32. Biomarkers on patient T cells diagnose active tuberculosis and monitor treatment response. Adekambi T; Ibegbu CC; Cagle S; Kalokhe AS; Wang YF; Hu Y; Day CL; Ray SM; Rengarajan J J Clin Invest; 2015 May; 125(5):1827-38. PubMed ID: 25822019 [TBL] [Abstract][Full Text] [Related]
33. A systematic review and meta-analysis of circulating serum and plasma microRNAs in TB diagnosis. Gunasekaran H; Sampath P; Thiruvengadam K; Malaisamy M; Ramasamy R; Ranganathan UD; Bethunaickan R BMC Infect Dis; 2024 Apr; 24(1):402. PubMed ID: 38622570 [TBL] [Abstract][Full Text] [Related]
34. Possible relation between expression of circulating microRNA and plasma cytokine levels in cases of pulmonary tuberculosis. Ulger M; Serin MS; Tezcan Ulger S; Aslan G; Ilvan A; Tiftik EN; Emekdas G J Infect Dev Ctries; 2022 Jul; 16(7):1166-1173. PubMed ID: 35905021 [TBL] [Abstract][Full Text] [Related]
35. Integrating serum microRNAs and electronic health records improved the diagnosis of tuberculosis. Gao SH; Chen CG; Zhuang CB; Zeng YL; Zeng ZZ; Wen PH; Yu YM; Ming L; Zhao JW J Clin Lab Anal; 2021 Aug; 35(8):e23871. PubMed ID: 34106501 [TBL] [Abstract][Full Text] [Related]
36. Integrated bioinformatics analysis and validation revealed potential immune-regulatory miR-892b, miR-199b-5p and miR-582-5p as diagnostic biomarkers in active tuberculosis. Zhang Y; Zhang X; Zhao Z; Zheng Y; Xiao Z; Li F Microb Pathog; 2019 Sep; 134():103563. PubMed ID: 31175974 [TBL] [Abstract][Full Text] [Related]
37. Long non-coding RNA SNHG16 silencing inhibits proliferation and inflammation in Mycobacterium tuberculosis-infected macrophages by targeting miR-140-5p expression. Sun W; Zhang X; He X; Zhang J; Wang X; Lin W; Wang X; Wu X Infect Genet Evol; 2022 Sep; 103():105325. PubMed ID: 35779785 [TBL] [Abstract][Full Text] [Related]
38. Acute and post-acute phase of COVID-19: Analyzing expression patterns of miRNA-29a-3p, 146a-3p, 155-5p, and let-7b-3p in PBMC. Donyavi T; Bokharaei-Salim F; Baghi HB; Khanaliha K; Alaei Janat-Makan M; Karimi B; Sadri Nahand J; Mirzaei H; Khatami A; Garshasbi S; Khoshmirsafa M; Jalal Kiani S Int Immunopharmacol; 2021 Aug; 97():107641. PubMed ID: 33895478 [TBL] [Abstract][Full Text] [Related]
39. Identification of a plasma microRNA profile in untreated pulmonary tuberculosis patients that is modulated by anti-mycobacterial therapy. Barry SE; Ellis M; Yang Y; Guan G; Wang X; Britton WJ; Saunders BM J Infect; 2018 Oct; 77(4):341-348. PubMed ID: 29746939 [TBL] [Abstract][Full Text] [Related]
40. Circulating microRNA-144-3p and miR-762 are novel biomarkers of Graves' disease. Yao Q; Wang X; He W; Song Z; Wang B; Zhang J; Qin Q Endocrine; 2019 Jul; 65(1):102-109. PubMed ID: 30949910 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]